{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:39:19Z","timestamp":1792787959384,"version":"4.5.0"},"reference-count":186,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["81860636"],"award-info":[{"award-number":["81860636"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Physical Exercise and Mental Health Research Project of Guangxi Science and Technology Normal University","award":["GXKSKYPT2025003"],"award-info":[{"award-number":["GXKSKYPT2025003"]}],"id":[{"id":"https:\/\/ror.org\/05fw37w31","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-03055-5","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:23:51Z","timestamp":1789176231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic dysfunction-associated steatotic liver disease: pathogenic mechanisms and exercise-induced molecular adaptations"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5984-5206","authenticated-orcid":false,"given":"Senlin","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasheng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songwei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"3055_CR1","doi-asserted-by":"publisher","first-page":"100586","DOI":"10.37349\/edd.2025.100586","volume":"4","author":"A Lonardo","year":"2025","unstructured":"Lonardo A, Zheng MH, Eslam M. MASLD vs. MAFLD. A narrative review. Exploration of Digestive Diseases. 2025;4:100586.","journal-title":"Exploration of Digestive Diseases"},{"issue":"3","key":"3055_CR2","doi-asserted-by":"publisher","first-page":"N","DOI":"10.20517\/mtod.2024.30","volume":"4","author":"H Desalegn","year":"2024","unstructured":"Desalegn H, Farias R, Hudson D, Idalsoaga F, Cabrera D, Diaz LA, et al. Prevention and control of risk factors in metabolic and alcohol-associated steatotic liver disease. Metabol Target Organ Damage. 2024;4(3):N.","journal-title":"Metabol Target Organ Damage"},{"issue":"11","key":"3055_CR3","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.3390\/ijms25115640","volume":"25","author":"P Portincasa","year":"2024","unstructured":"Portincasa P, Khalil M, Mahdi L, Perniola V, Idone V, Graziani A, et al. Metabolic dysfunction\u2013associated steatotic liver disease: from pathogenesis to current therapeutic options. Int J Mol Sci. 2024;25(11):5640.","journal-title":"Int J Mol Sci"},{"issue":"Suppl","key":"3055_CR4","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(Suppl):S32-s50.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"3055_CR5","doi-asserted-by":"publisher","first-page":"101898","DOI":"10.1016\/j.aohep.2025.101898","volume":"30","author":"C Kan","year":"2025","unstructured":"Kan C, Zhang K, Wang Y, Zhang X, Liu C, Ma Y, et al. Global burden and future trends of metabolic dysfunction-associated Steatotic liver disease: 1990\u20132021 to 2045. Ann Hepatol. 2025;30(2):101898.","journal-title":"Ann Hepatol"},{"issue":"17","key":"3055_CR6","doi-asserted-by":"publisher","first-page":"e0576","DOI":"10.1097\/MD.0000000000010576","volume":"97","author":"X Liu","year":"2018","unstructured":"Liu X, Peng Y, Chen S, Sun Q. An observational study on the association between major dietary patterns and non-alcoholic fatty liver disease in Chinese adolescents. Medicine. 2018;97(17):e0576.","journal-title":"Medicine"},{"issue":"6","key":"3055_CR7","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386.","journal-title":"Hepatology"},{"issue":"7","key":"3055_CR8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"issue":"3","key":"3055_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","volume":"16","author":"K Kazankov","year":"2019","unstructured":"Kazankov K, J\u00f8rgensen SMD, Thomsen KL, M\u00f8ller HJ, Vilstrup H, George J, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):145\u201359.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"3055_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18(3):151\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"3055_CR11","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40(12):1461\u20135.","journal-title":"Nat Genet"},{"issue":"5","key":"3055_CR12","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017;65(5):1557\u201365.","journal-title":"Hepatology"},{"issue":"2","key":"3055_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/HEP.0000000000000735","volume":"82","author":"S Driessen","year":"2025","unstructured":"Driessen S, Francque SM, Anker SD, Cabezas MC, Grobbee DE, Tushuizen ME, et al. Metabolic dysfunction-associated steatotic liver disease and the heart. Hepatology. 2025;82(2):487\u2013503.","journal-title":"Hepatology"},{"issue":"6","key":"3055_CR14","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1097\/HEP.0000000000001254","volume":"82","author":"M Souza","year":"2025","unstructured":"Souza M, Al-Sharif L, Antunes VL, Huang DQ, Loomba R. Comparison of pharmacological therapies in metabolic dysfunction\u2013associated steatohepatitis for fibrosis regression and MASH resolution: systematic review and network meta-analysis. Hepatology. 2025;82(6):1523\u201333.","journal-title":"Hepatology"},{"issue":"4","key":"3055_CR15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793\u2013801.","journal-title":"J Hepatol"},{"issue":"2","key":"3055_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367-78. e5.","journal-title":"Gastroenterology"},{"issue":"2","key":"3055_CR17","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3390\/ijms27021066","volume":"27","author":"EM Mastoridou","year":"2026","unstructured":"Mastoridou EM, Goussia AC, Kataki A, Koniaris E, Glantzounis GK, Papoudou-Bai A, et al. The interplay between cellular senescence and lipid metabolism in the progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Int J Mol Sci. 2026;27(2):1066.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3055_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, et al. A phase 3, randomized, controlled trial of resmetirom in NASH with Liver fibrosis. N Engl J Med. 2024;390(6):497\u2013509.","journal-title":"N Engl J Med"},{"issue":"21","key":"3055_CR19","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","volume":"392","author":"AJ Sanyal","year":"2025","unstructured":"Sanyal AJ, Newsome PN, Kliers I, \u00d8stergaard LH, Long MT, Kj\u00e6r MS, et al. Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis. N Engl J Med. 2025;392(21):2089\u201399.","journal-title":"N Engl J Med"},{"key":"3055_CR20","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.34133\/research.1001","volume":"8","author":"D Yang","year":"2025","unstructured":"Yang D, Li L, Zang K, Ma W, Yang Y, Sun Y, et al. EVA1A regulates hepatic lipid homeostasis by modulating CD36 expression and its palmitoylation. Research. 2025;8:1001.","journal-title":"Research"},{"key":"3055_CR21","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1038\/s41467-026-69736-y","volume":"17","author":"H-T Xiao","year":"2026","unstructured":"Xiao H-T, Song P, Jin J, Wang Y-D, Xu Y-Y, Wu H, et al. GCN5 drives MASLD progression through LXR\u03b1\/SREBP1c signaling pathway\u2013mediated de novo lipogenesis. Nat Commun. 2026;17:2821.","journal-title":"Nat Commun"},{"key":"3055_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41419-026-08682-5","volume":"17","author":"R Liu","year":"2026","unstructured":"Liu R, Chen J, Wang J, Zhang T, Xia Y, Feng J, et al. Hepatocyte TIA1 constrains metabolic steatohepatitis by translationally suppressing Srebf1 mRNA in stress granules. Cell Death Dis. 2026;17:357.","journal-title":"Cell Death Dis"},{"issue":"51","key":"3055_CR23","doi-asserted-by":"publisher","first-page":"33047","DOI":"10.1074\/jbc.271.51.33047","volume":"271","author":"DA Gordon","year":"1996","unstructured":"Gordon DA, Jamil H, Gregg RE, Olofsson SO, Bor\u00e9n J. Inhibition of the microsomal triglyceride transfer protein blocks the first step of apolipoprotein B lipoprotein assembly but not the addition of bulk core lipids in the second step. J Biol Chem. 1996;271(51):33047\u201353.","journal-title":"J Biol Chem"},{"issue":"11","key":"3055_CR24","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/S0022-2275(20)32437-8","volume":"40","author":"UJ Tietge","year":"1999","unstructured":"Tietge UJ, Bakillah A, Maugeais C, Tsukamoto K, Hussain M, Rader DJ. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J Lipid Res. 1999;40(11):2134\u20139.","journal-title":"J Lipid Res"},{"issue":"4","key":"3055_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","volume":"49","author":"M Adiels","year":"2006","unstructured":"Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 2006;49(4):755\u201365.","journal-title":"Diabetologia"},{"issue":"2","key":"3055_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","volume":"134","author":"E Fabbrini","year":"2008","unstructured":"Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology. 2008;134(2):424\u201331.","journal-title":"Gastroenterology"},{"issue":"3","key":"3055_CR27","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jcmgh.2021.11.007","volume":"13","author":"M Longo","year":"2022","unstructured":"Longo M, Meroni M, Paolini E, Erconi V, Carli F, Fortunato F, et al. TM6SF2\/PNPLA3\/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and in in vitro models. Cell Mol Gastroenterol Hepatol. 2022;13(3):759\u201388.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3055_CR28","doi-asserted-by":"publisher","first-page":"100031","DOI":"10.1194\/jlr.RA120000856","volume":"62","author":"M Xia","year":"2021","unstructured":"Xia M, Chandrasekaran P, Rong S, Fu X, Mitsche MA. Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver. J Lipid Res. 2021;62:100031.","journal-title":"J Lipid Res"},{"issue":"12","key":"3055_CR29","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","volume":"378","author":"NS Abul-Husn","year":"2018","unstructured":"Abul-Husn NS, Cheng X, Li AH, Xin Y, Schurmann C, Stevis P, et al. A protein-truncating HSD17B13 variant and protection from chronic liver disease. N Engl J Med. 2018;378(12):1096\u2013106.","journal-title":"N Engl J Med"},{"issue":"8","key":"3055_CR30","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1113\/EP092535","volume":"110","author":"S Mahmood","year":"2025","unstructured":"Mahmood S, Morrice N, Thompson D, Milanizadeh S, Wilson S, Whitfield PD, et al. Hydroxysteroid 17\u03b2-dehydrogenase 13 (Hsd17b13) knockdown attenuates liver steatosis in high-fat diet obese mice. Exp Physiol. 2025;110(8):1071\u201386.","journal-title":"Exp Physiol"},{"issue":"18","key":"3055_CR31","doi-asserted-by":"publisher","first-page":"e2318619121","DOI":"10.1073\/pnas.2318619121","volume":"121","author":"DJ Sherman","year":"2024","unstructured":"Sherman DJ, Liu L, Mamrosh JL, Xie J, Ferbas J, Lomenick B, et al. The fatty liver disease\u2013causing protein PNPLA3-I148M alters lipid droplet\u2013Golgi dynamics. Proc Natl Acad Sci U S A. 2024;121(18):e2318619121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3055_CR32","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1038\/s41467-024-49224-x","volume":"15","author":"SM Johnson","year":"2024","unstructured":"Johnson SM, Bao H, McMahon CE, Chen Y, Burr SD, Anderson AM, et al. PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein. Nat Commun. 2024;15(1):4847.","journal-title":"Nat Commun"},{"issue":"12","key":"3055_CR33","doi-asserted-by":"publisher","first-page":"101185","DOI":"10.1016\/j.jhepr.2024.101185","volume":"6","author":"F Carli","year":"2024","unstructured":"Carli F, Della Pepa G, Sabatini S, Puig AV, Gastaldelli A. Lipid metabolism in MASLD and MASH: From mechanism to the clinic. JHEP Reports. 2024;6(12):101185.","journal-title":"JHEP Reports"},{"issue":"9","key":"3055_CR34","doi-asserted-by":"publisher","first-page":"113449","DOI":"10.1016\/j.isci.2025.113449","volume":"28","author":"M Meroni","year":"2025","unstructured":"Meroni M, Paolini E, Longo M, Battistin M, Dondossola D, Ripolone M, et al. Exploring multiorgan mitochondrial dysfunction in the switch toward progressive MASLD in AMLN mice. iScience. 2025;28(9):113449.","journal-title":"iScience"},{"issue":"1","key":"3055_CR35","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1038\/s41467-020-16991-2","volume":"11","author":"L Barbier-Torres","year":"2020","unstructured":"Barbier-Torres L, Fortner KA, Iruzubieta P, Delgado TC, Giddings E, Chen Y, et al. Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation. Nat Commun. 2020;11(1):3360.","journal-title":"Nat Commun"},{"issue":"1","key":"3055_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13578-024-01315-4","volume":"14","author":"S Li","year":"2024","unstructured":"Li S, Chen F, Liu M, Zhang Y, Xu J, Li X, et al. Knockdown of hepatic mitochondrial calcium uniporter mitigates MASH and fibrosis in mice. Cell Biosci. 2024;14(1):135.","journal-title":"Cell Biosci"},{"issue":"1","key":"3055_CR37","doi-asserted-by":"publisher","first-page":"28167","DOI":"10.1038\/s41598-024-78935-w","volume":"14","author":"Q Liao","year":"2024","unstructured":"Liao Q, Zhang Y, Pan T, Sun Y, Liu S, Zhang Z, et al. Liver knockout of MCU leads to greater dysregulation of lipid metabolism in MAFLD. Sci Rep. 2024;14(1):28167.","journal-title":"Sci Rep"},{"key":"3055_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-026-01648-9","volume":"58","author":"WJ Cao","year":"2026","unstructured":"Cao WJ, Su R, Fu HL, Wu JJ, Huang LS, Liu FF, et al. Supplementation of L-aspartate corrects MASLD and MASH in mice by inhibiting platelet\u2013hepatocyte interaction-mediated mitochondrial fragmentation via the ATP\u2013P2X7\u2013NEK7\u2013DRP1 axis. Exp Mol Med. 2026;58:1\u201315.","journal-title":"Exp Mol Med"},{"key":"3055_CR39","doi-asserted-by":"publisher","first-page":"e18974","DOI":"10.1002\/advs.202518974","volume":"13","author":"Y Jiang","year":"2026","unstructured":"Jiang Y, Tong T, Shi P, Chen X, Wang C, Weng Q, et al. Targeted mitochondrial ECSIT overexpression attenuates MASH by increasing OTUD3 expression. Adv Sci. 2026;13:e18974.","journal-title":"Adv Sci"},{"key":"3055_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-025-08294-5","volume":"17","author":"L Che","year":"2025","unstructured":"Che L, Stevenson CK, Plas DR, Wang J, Du C. BRUCE liver-KO enhances MASLD\/MASH development in the steatotic PTEN-KO background by impairing mitochondrial metabolism and activating STAT3. Cell Death Dis. 2025;17:88.","journal-title":"Cell Death Dis"},{"issue":"17","key":"3055_CR41","doi-asserted-by":"publisher","first-page":"12093","DOI":"10.1074\/jbc.M510660200","volume":"281","author":"H Malhi","year":"2006","unstructured":"Malhi H, Bronk SF, Werneburg NW, Gores GJ. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem. 2006;281(17):12093\u2013101.","journal-title":"J Biol Chem"},{"key":"3055_CR42","doi-asserted-by":"publisher","first-page":"119053","DOI":"10.1016\/j.atherosclerosis.2024.119053","volume":"400","author":"S Iturbe-Rey","year":"2025","unstructured":"Iturbe-Rey S, Maccali C, Arrese M, Aspichueta P, Oliveira CP, Castro RE, et al. Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD). Atherosclerosis. 2025;400:119053.","journal-title":"Atherosclerosis"},{"issue":"46","key":"3055_CR43","doi-asserted-by":"publisher","first-page":"e08576","DOI":"10.1002\/advs.202508576","volume":"12","author":"Y Wang","year":"2025","unstructured":"Wang Y, Deng Y, Chen J, Hahn Q, Umbaugh DS, Zhang Z, et al. cGAS inhibits ALDH2 to suppress lipid droplet function and regulate MASLD progression. Adv Sci (Weinh). 2025;12(46):e08576.","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"3055_CR44","doi-asserted-by":"publisher","first-page":"115251","DOI":"10.1016\/j.celrep.2025.115251","volume":"44","author":"M Chen","year":"2025","unstructured":"Chen M, Li Y, Zhu J-Y, Mu W-J, Luo H-Y, Yan L-J, et al. Exercise-induced adipokine Nrg4 alleviates MASLD by disrupting hepatic cGAS-STING signaling. Cell Rep. 2025;44(2):115251.","journal-title":"Cell Rep"},{"issue":"22","key":"3055_CR45","doi-asserted-by":"publisher","first-page":"16354","DOI":"10.3390\/ijms242216354","volume":"24","author":"S Roy","year":"2023","unstructured":"Roy S, Saha P, Bose D, Trivedi A, More M, Xiao S, et al. Hepatic NLRP3-derived Hsp70 binding to TLR4 mediates MASLD to MASH Progression upon inhibition of PP2A by harmful algal bloom toxin microcystin, a second Hit. Int J Mol Sci. 2023;24(22):16354.","journal-title":"Int J Mol Sci"},{"key":"3055_CR46","doi-asserted-by":"publisher","first-page":"117527","DOI":"10.1016\/j.taap.2025.117527","volume":"504","author":"P Saha","year":"2025","unstructured":"Saha P, Bose D, Roy S, More M, Trivedi A, Brooks BW, et al. Peroxynitrite is key to Cylindrospermopsin-mediated MASLD to MASH progression via triggering TXNIP binding to NLRP3 and subsequent inflammasome activation. Toxicol Appl Pharmacol. 2025;504:117527.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"11","key":"3055_CR47","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1136\/gutjnl-2023-331447","volume":"73","author":"M Babuta","year":"2024","unstructured":"Babuta M, Morel C, de Carvalho RM, Calenda C, Ortega-Ribera M, Thevkar Nagesh P, et al. Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis. Gut. 2024;73(11):1854\u201369.","journal-title":"Gut"},{"issue":"1","key":"3055_CR48","doi-asserted-by":"publisher","first-page":"e191479","DOI":"10.1172\/jci.insight.191479","volume":"11","author":"J Shen","year":"2026","unstructured":"Shen J, Huang S, Wang Y, Wang Q, Lin S, Guan W, et al. PAD4+ neutrophils promote hepatic stellate cell activation and accelerate MASH fibrosis progression viaNET-DNA\/TAOK1\/MAPK pathways. JCI Insight. 2026;11(1):e191479.","journal-title":"JCI Insight"},{"issue":"764","key":"3055_CR49","doi-asserted-by":"publisher","first-page":"eadi0284","DOI":"10.1126\/scitranslmed.adi0284","volume":"16","author":"I Jeelani","year":"2024","unstructured":"Jeelani I, Moon JS, da Cunha FF, Nasamran CA, Jeon S, Zhang X, et al. HIF-2\u03b1 drives hepatic Kupffer cell death and proinflammatory recruited macrophage activation in nonalcoholic steatohepatitis. Sci Transl Med. 2024;16(764):eadi0284.","journal-title":"Sci Transl Med"},{"issue":"1","key":"3055_CR50","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cgh.2023.04.003","volume":"22","author":"QM Anstee","year":"2024","unstructured":"Anstee QM, Neuschwander-Tetri BA, Wong VW-S, Abdelmalek MF, Rodriguez-Araujo G, Landgren H, et al. Cenicriviroc lacked efficacy to treat liver fibrosis in nonalcoholic steatohepatitis: AURORA phase III randomized study. Clin Gastroenterol Hepatol. 2024;22(1):124-34. e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"3055_CR51","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.immuni.2024.08.016","volume":"57","author":"W Guo","year":"2024","unstructured":"Guo W, Li Z, Anagnostopoulos G, Kong WT, Zhang S, Chakarov S, et al. Notch signaling regulates macrophage-mediated inflammation in metabolic dysfunction-associated steatotic liver disease. Immunity. 2024;57(10):2310-27.e6.","journal-title":"Immunity"},{"key":"3055_CR52","doi-asserted-by":"crossref","unstructured":"He J, Chen B, Lu W, Wang X, Yang R, Deng C, et al. Differential regulation of hepatic macrophage fate by Chi3l1 in MASLD. bioRxiv. 2025:2025.05. 06.652369.","DOI":"10.7554\/eLife.107023.1"},{"issue":"6","key":"3055_CR53","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.immuni.2020.04.001","volume":"52","author":"JS Seidman","year":"2020","unstructured":"Seidman JS, Troutman TD, Sakai M, Gola A, Spann NJ, Bennett H, et al. Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis. Immunity. 2020;52(6):1057-74.e7.","journal-title":"Immunity"},{"key":"3055_CR54","doi-asserted-by":"publisher","first-page":"155911","DOI":"10.1016\/j.metabol.2024.155911","volume":"155","author":"W Yu","year":"2024","unstructured":"Yu W, Zhang Y, Sun L, Huang W, Li X, Xia N, et al. Myeloid Trem2 ameliorates the progression of metabolic dysfunction-associated steatotic liver disease by regulating macrophage pyroptosis and inflammation resolution. Metabolism. 2024;155:155911.","journal-title":"Metabolism"},{"key":"3055_CR55","doi-asserted-by":"publisher","first-page":"156453","DOI":"10.1016\/j.metabol.2025.156453","volume":"175","author":"J Liu","year":"2025","unstructured":"Liu J, Wu H, Zhou L, Jin Q, Ji H, Hu B, et al. DC-SIGN+ macrophages alleviate metabolic dysfunction-associated steatotic liver disease via fine-tuning TLR4 signaling and inflammatory secretory profiles. Metabolism. 2025;175:156453.","journal-title":"Metabolism"},{"issue":"672","key":"3055_CR56","doi-asserted-by":"publisher","first-page":"eabp8309","DOI":"10.1126\/scitranslmed.abp8309","volume":"14","author":"H Shi","year":"2022","unstructured":"Shi H, Wang X, Li F, Gerlach BD, Yurdagul A Jr, Moore MP, et al. CD47-SIRP\u03b1 axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis. Sci Transl Med. 2022;14(672):eabp8309.","journal-title":"Sci Transl Med"},{"issue":"2","key":"3055_CR57","doi-asserted-by":"publisher","first-page":"876","DOI":"10.7150\/ijbs.125688","volume":"22","author":"G Yin","year":"2026","unstructured":"Yin G, Liu Y, Teng X, Sun S, Chen B, Wang X, et al. Hepatocyte SAMHD1 deficiency attenuates hepatic steatosis via suppression of SREBP activation in a mouse model of metabolic-associated steatotic liver disease. Int J Biol Sci. 2026;22(2):876.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3055_CR58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s44324-026-00099-0","volume":"4","author":"M Kuroda","year":"2026","unstructured":"Kuroda M, Nomura K, Wada A, Hatano Y, Ogawa M, Okamoto S, et al. Adipose tissue\u2013derived MFG-E8 promotes hepatic inflammation and fibrosis through macrophage activation in a mouse MASH model. npj Metab Health Dis. 2026;4(1):8.","journal-title":"npj Metab Health Dis"},{"issue":"3","key":"3055_CR59","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.26592","volume":"59","author":"A Wree","year":"2014","unstructured":"Wree A, Eguchi A, McGeough MD, Pena CA, Johnson CD, Canbay A, et al. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology. 2014;59(3):898\u2013910.","journal-title":"Hepatology"},{"issue":"4","key":"3055_CR60","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2017.11.040","volume":"68","author":"B Xu","year":"2018","unstructured":"Xu B, Jiang M, Chu Y, Wang W, Chen D, Li X, et al. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. J Hepatol. 2018;68(4):773\u201382.","journal-title":"J Hepatol"},{"issue":"7","key":"3055_CR61","doi-asserted-by":"publisher","first-page":"e0479","DOI":"10.1097\/HC9.0000000000000479","volume":"8","author":"M Sheng","year":"2024","unstructured":"Sheng M, Huo S, Jia L, Weng Y, Liu W, Lin Y, et al. NUAK1 promotes metabolic dysfunction-associated steatohepatitis progression by activating Caspase 6\u2013driven pyroptosis and inflammation. Hepatology communications. 2024;8(7):e0479.","journal-title":"Hepatology communications"},{"issue":"1","key":"3055_CR62","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1186\/s12967-025-07302-8","volume":"23","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Chen L, Liu J-Y, Liu T, Wang R, Wu X-Y, et al. MPTP mediated Ox-mtDNA release inducing macrophage pyroptosis and exacerbating MCD-induced MASH via promoting the ITPR3\/Ca2+\/NLRP3 pathway. J Transl Med. 2025;23(1):1289.","journal-title":"J Transl Med"},{"issue":"1","key":"3055_CR63","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1507\/endocrj.EJ25-0168","volume":"73","author":"Y Inaba","year":"2026","unstructured":"Inaba Y, Tsuchiya K, Inoue H. Shifting cell death modes in hepatic steatosis: from apoptosis to necroptosis. Endocr J. 2026;73(1):13\u201320.","journal-title":"Endocr J"},{"issue":"4","key":"3055_CR64","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/s41418-020-00668-w","volume":"28","author":"L Tao","year":"2021","unstructured":"Tao L, Yi Y, Chen Y, Zhang H, Orning P, Lien E, et al. RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages. Cell Death Differ. 2021;28(4):1418\u201333.","journal-title":"Cell Death Differ"},{"key":"3055_CR65","doi-asserted-by":"publisher","first-page":"12464","DOI":"10.1038\/s41598-026-45476-3","volume":"16","author":"H Yang","year":"2026","unstructured":"Yang H, Shi Z, Qi Y, Bao S, Li C, Mei J, et al. Palmatine ameliorates MASLD in type 2 diabetes by modulating hepatic apoptosis and inflammation. Sci Rep. 2026;16:12464.","journal-title":"Sci Rep"},{"issue":"2","key":"3055_CR66","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jhep.2023.10.025","volume":"80","author":"Z Lei","year":"2024","unstructured":"Lei Z, Yu J, Wu Y, Shen J, Lin S, Xue W, et al. CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis. J Hepatol. 2024;80(2):194\u2013208.","journal-title":"J Hepatol"},{"issue":"1","key":"3055_CR67","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12974-018-1235-0","volume":"15","author":"YK Dhuriya","year":"2018","unstructured":"Dhuriya YK, Sharma D. Necroptosis: a regulated inflammatory mode of cell death. J Neuroinflammation. 2018;15(1):199.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"3055_CR68","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.15252\/emmm.201403856","volume":"6","author":"J Gautheron","year":"2014","unstructured":"Gautheron J, Vucur M, Reisinger F, Cardenas DV, Roderburg C, Koppe C, et al. A positive feedback loop between RIP3 and JNK controls non\u2010alcoholic steatohepatitis. EMBO Mol Med. 2014;6(8):1062\u201374.","journal-title":"EMBO Mol Med"},{"issue":"12","key":"3055_CR69","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1136\/gutjnl-2020-321767","volume":"70","author":"MB Afonso","year":"2021","unstructured":"Afonso MB, Rodrigues PM, Mateus-Pinheiro M, Sim\u00e3o AL, Gaspar MM, Majdi A, et al. RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease. Gut. 2021;70(12):2359\u201372.","journal-title":"Gut"},{"issue":"12","key":"3055_CR70","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.chembiol.2017.08.026","volume":"24","author":"LR Parisi","year":"2017","unstructured":"Parisi LR, Li N, Atilla-Gokcumen GE. Very long chain fatty acids are functionally involved in necroptosis. Cell Chem Biol. 2017;24(12):1445-54. e8.","journal-title":"Cell Chem Biol"},{"issue":"2","key":"3055_CR71","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1074\/jbc.RA118.005865","volume":"294","author":"R Nganga","year":"2019","unstructured":"Nganga R, Oleinik N, Kim J, Selvam SP, De Palma R, Johnson KA, et al. Receptor-interacting Ser\/Thr kinase 1 (RIPK1) and myosin IIA\u2013dependent ceramidosomes form membrane pores that mediate blebbing and necroptosis. J Biol Chem. 2019;294(2):502\u201319.","journal-title":"J Biol Chem"},{"issue":"4","key":"3055_CR72","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jhep.2019.11.008","volume":"72","author":"A Majdi","year":"2020","unstructured":"Majdi A, Aoudjehane L, Ratziu V, Islam T, Afonso MB, Conti F, et al. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease. J Hepatol. 2020;72(4):627\u201335.","journal-title":"J Hepatol"},{"issue":"1","key":"3055_CR73","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41420-020-0240-0","volume":"6","author":"H Brito","year":"2020","unstructured":"Brito H, Marques V, Afonso MB, Brown DG, B\u00f6rjesson U, Selmi N, et al. Phenotypic high-throughput screening platform identifies novel chemotypes for necroptosis inhibition. Cell Death Discov. 2020;6(1):6.","journal-title":"Cell Death Discov"},{"key":"3055_CR74","doi-asserted-by":"publisher","first-page":"42159","DOI":"10.1038\/srep42159","volume":"7","author":"Q Wang","year":"2017","unstructured":"Wang Q, Zhou T, Liu Z, Ren J, Phan N, Gupta K, et al. Inhibition of receptor-interacting protein kinase 1 with Necrostatin-1s ameliorates disease progression in elastase-induced mouse abdominal aortic aneurysm model. Sci Rep. 2017;7:42159.","journal-title":"Sci Rep"},{"issue":"6","key":"3055_CR75","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster S, Cabrera D, Arrese M, Feldstein AE. Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol. 2018;15(6):349\u201364.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"3055_CR76","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jhep.2020.03.023","volume":"73","author":"X Wu","year":"2020","unstructured":"Wu X, Poulsen KL, Sanz-Garcia C, Huang E, McMullen MR, Roychowdhury S, et al. MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis. J Hepatol. 2020;73(3):616\u201327.","journal-title":"J Hepatol"},{"issue":"5","key":"3055_CR77","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"9","key":"3055_CR78","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41418-024-01348-9","volume":"31","author":"C Peleman","year":"2024","unstructured":"Peleman C, Hellemans S, Veeckmans G, Arras W, Zheng H, Koeken I, et al. Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease. Cell Death Differ. 2024;31(9):1113\u201326.","journal-title":"Cell Death Differ"},{"issue":"23","key":"3055_CR79","doi-asserted-by":"publisher","first-page":"e193805","DOI":"10.1172\/jci.insight.193805","volume":"10","author":"RM Florentino","year":"2025","unstructured":"Florentino RM, Animasahun O, Haep N, Nenwani M, Omoloja K, Altay LN, et al. PNPLA3-I148M genetic variant rewires lipid metabolism to drive programmed cell death in human hepatocytes. JCI insight. 2025;10(23):e193805.","journal-title":"JCI insight"},{"issue":"4","key":"3055_CR80","doi-asserted-by":"publisher","first-page":"115478","DOI":"10.1016\/j.isci.2026.115478","volume":"29","author":"T Wang","year":"2026","unstructured":"Wang T, Sheng F, Lian C, Lv Z, Yao J, Cao X, et al. OSBPL2 deficiency alleviates diet-induced MASLD by reducing ACSL4-mediated ferroptosis. iScience. 2026;29(4):115478.","journal-title":"iScience"},{"key":"3055_CR81","doi-asserted-by":"publisher","first-page":"1283170","DOI":"10.3389\/fmmed.2023.1283170","volume":"3","author":"C Theys","year":"2024","unstructured":"Theys C, Vanderhaeghen T, Van Dijck E, Peleman C, Scheepers A, Ibrahim J, et al. Loss of PPAR\u03b1 function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD). Front Mol Med. 2024;3:1283170.","journal-title":"Front Mol Med"},{"key":"3055_CR82","first-page":"12","volume":"3","author":"Y Gong","year":"2026","unstructured":"Gong Y, Chen J, Zhang F, Huang R, Mai L, Xu Y, et al. Genome-wide CRISPR screen identifies TAF1C as an epigenetic determinant of lipid deposition via ACSL4-dependent ferroptosis in MASLD. J Adv Res. 2026;3:12.","journal-title":"J Adv Res"},{"issue":"1","key":"3055_CR83","doi-asserted-by":"publisher","first-page":"7575","DOI":"10.1038\/s41598-023-34710-x","volume":"13","author":"R Undamatla","year":"2023","unstructured":"Undamatla R, Fagunloye O, Chen J, Edmunds L, Murali A, Mills A, et al. Reduced mitophagy is an early feature of NAFLD and liver-specific PARKIN knockout hastens the onset of steatosis, inflammation and fibrosis. Sci Rep. 2023;13(1):7575.","journal-title":"Sci Rep"},{"key":"3055_CR84","doi-asserted-by":"publisher","first-page":"1162485","DOI":"10.3389\/fendo.2023.1162485","volume":"14","author":"Y-Y Zou","year":"2023","unstructured":"Zou Y-Y, Tang X-b, Chen Z-L, Liu B, Zheng L, Song M-Y, et al. Exercise intervention improves mitochondrial quality in non-alcoholic fatty liver disease zebrafish. Front Endocrinol. 2023;14:1162485.","journal-title":"Front Endocrinol"},{"issue":"7","key":"3055_CR85","doi-asserted-by":"publisher","first-page":"e70277","DOI":"10.1002\/mco2.70277","volume":"6","author":"K He","year":"2025","unstructured":"He K, Zhan M, Luo X, Li R, Lin L, Lin J, et al. Casein kinase 2\u03b1 ablation confers protection against metabolic dysfunction-associated steatotic liver disease: role of FUN14 domain containing 1-Dependent regulation of mitophagy and ferroptosis. MedComm. 2025;6(7):e70277.","journal-title":"MedComm"},{"key":"3055_CR86","doi-asserted-by":"publisher","first-page":"1449178","DOI":"10.3389\/fphar.2024.1449178","volume":"15","author":"J Lin","year":"2024","unstructured":"Lin J, Huang C, Zhao J, Li L, Wu Z, Zhang T, et al. The novel TFEB agonist desloratadine ameliorates hepatic steatosis by activating the autophagy-lysosome pathway. Front Pharmacol. 2024;15:1449178.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3055_CR87","doi-asserted-by":"publisher","first-page":"7570","DOI":"10.1038\/s41467-025-63022-z","volume":"16","author":"Q Ouyang","year":"2025","unstructured":"Ouyang Q, Su J, Li Y, Liao H, Guo H, Sun Y, et al. Dysregulation of GTPase-activating protein-binding protein1 in the pathogenesis of metabolic dysfunction-associated steatotic liver disease. Nat Commun. 2025;16(1):7570.","journal-title":"Nat Commun"},{"issue":"7242","key":"3055_CR88","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nature07976","volume":"458","author":"R Singh","year":"2009","unstructured":"Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, et al. Autophagy regulates lipid metabolism. Nature. 2009;458(7242):1131\u20135.","journal-title":"Nature"},{"issue":"1","key":"3055_CR89","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1038\/s41467-023-39404-6","volume":"14","author":"Y Minami","year":"2023","unstructured":"Minami Y, Hoshino A, Higuchi Y, Hamaguchi M, Kaneko Y, Kirita Y, et al. Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretion. Nat Commun. 2023;14(1):4084.","journal-title":"Nat Commun"},{"issue":"7","key":"3055_CR90","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1080\/15548627.2017.1319544","volume":"13","author":"T-H Tsai","year":"2017","unstructured":"Tsai T-H, Chen E, Li L, Saha P, Lee H-J, Huang L-S, et al. The constitutive lipid droplet protein PLIN2 regulates autophagy in liver. Autophagy. 2017;13(7):1130\u201344.","journal-title":"Autophagy"},{"issue":"3","key":"3055_CR91","doi-asserted-by":"publisher","first-page":"167045","DOI":"10.1016\/j.bbadis.2024.167045","volume":"1870","author":"C Fang","year":"2024","unstructured":"Fang C, Liu S, Yang W, Zheng G, Zhou F, Gao X, et al. Exercise ameliorates lipid droplet metabolism disorder by the PLIN2\u2013LIPA axis-mediated lipophagy in mouse model of non-alcoholic fatty liver disease. Biochim Biophys Acta Mol Basis Dis. 2024;1870(3):167045.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"21","key":"3055_CR92","doi-asserted-by":"publisher","first-page":"2414646","DOI":"10.1002\/advs.202414646","volume":"12","author":"H Zhang","year":"2025","unstructured":"Zhang H, Kong X, Wang W, Zhou H, Qu H, Guan Z, et al. TRIM25-Mediated INSIG1 ubiquitination promotes MASH progression through reprogramming lipid metabolism. Advanced Science. 2025;12(21):2414646.","journal-title":"Advanced Science"},{"issue":"1","key":"3055_CR93","doi-asserted-by":"publisher","first-page":"8519","DOI":"10.1038\/s41467-024-53002-0","volume":"15","author":"H Rho","year":"2024","unstructured":"Rho H, Kim S, Kim SU, Kim JW, Lee SH, Park SH, et al. CHIP ameliorates nonalcoholic fatty liver disease via promoting K63- and K27-linked STX17 ubiquitination to facilitate autophagosome-lysosome fusion. Nat Commun. 2024;15(1):8519.","journal-title":"Nat Commun"},{"issue":"1","key":"3055_CR94","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41419-025-08210-x","volume":"17","author":"Y Qin","year":"2026","unstructured":"Qin Y, Teker SS, La Cunza N, Tong Y, Theusch E, Yang NV, et al. Loss of TMEM55B modulates lipid metabolism through dysregulated lipophagy and mitochondrial function. Cell Death Dis. 2026;17(1):26.","journal-title":"Cell Death Dis"},{"issue":"10","key":"3055_CR95","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1038\/s41418-025-01507-6","volume":"32","author":"S Zhang","year":"2025","unstructured":"Zhang S, Li G, He L, Wang F, Gao M, Dai T, et al. Sphingosine kinase 2 deficiency impairs VLDL secretion by inhibiting mTORC2 phosphorylation and activating chaperone-mediated autophagy. Cell Death Differ. 2025;32(10):1886\u201399.","journal-title":"Cell Death Differ"},{"issue":"9","key":"3055_CR96","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41575-025-01089-1","volume":"22","author":"HCH Lau","year":"2025","unstructured":"Lau HCH, Zhang X, Yu J. Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2025;22(9):619\u201338.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"3055_CR97","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, De Gottardi A, Rescigno M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol. 2020;72(3):558\u201377.","journal-title":"J Hepatol"},{"issue":"5","key":"3055_CR98","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","volume":"25","author":"R Loomba","year":"2017","unstructured":"Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, et al. Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease. Cell Metab. 2017;25(5):1054-62. e5.","journal-title":"Cell Metab"},{"issue":"8","key":"3055_CR99","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1111\/jgh.15487","volume":"36","author":"M Iwaki","year":"2021","unstructured":"Iwaki M, Kessoku T, Ozaki A, Kasai Y, Kobayashi T, Nogami A, et al. Gut microbiota composition associated with hepatic fibrosis in non\u2010obese patients with non\u2010alcoholic fatty liver disease. J Gastroenterol Hepatol. 2021;36(8):2275\u201384.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"3055_CR100","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41401-020-00581-5","volume":"42","author":"QX Mei","year":"2021","unstructured":"Mei QX, Hu JH, Huang ZH, Fan JJ, Huang CL, Lu YY, et al. Pretreatment with chitosan oligosaccharides attenuate experimental severe acute pancreatitis via inhibiting oxidative stress and modulating intestinal homeostasis. Acta Pharmacol Sin. 2021;42(6):942\u201353.","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"3055_CR101","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jcmgh.2023.08.001","volume":"16","author":"B Shen","year":"2023","unstructured":"Shen B, Gu T, Shen Z, Zhou C, Guo Y, Wang J, et al. Escherichia coli promotes endothelial to mesenchymal transformation of liver sinusoidal endothelial cells and exacerbates nonalcoholic fatty liver disease via its flagellin. Cell Mol Gastroenterol Hepatol. 2023;16(6):857\u201379.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"7","key":"3055_CR102","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/labinvest.3700422","volume":"86","author":"YH Paik","year":"2006","unstructured":"Paik YH, Lee KS, Lee HJ, Yang KM, Lee SJ, Lee DK, et al. Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid. Lab Invest. 2006;86(7):676\u201386.","journal-title":"Lab Invest"},{"issue":"8","key":"3055_CR103","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/cmi.2015.111","volume":"14","author":"X Hou","year":"2017","unstructured":"Hou X, Hao X, Zheng M, Xu C, Wang J, Zhou R, et al. CD205-TLR9-IL-12 axis contributes to CpG-induced oversensitive liver injury in HBsAg transgenic mice by promoting the interaction of NKT cells with Kupffer cells. Cell Mol Immunol. 2017;14(8):675\u201384.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"3055_CR104","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","volume":"30","author":"J Yuan","year":"2019","unstructured":"Yuan J, Chen C, Cui J, Lu J, Yan C, Wei X, et al. Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell metabolism. 2019;30(4):675-88 e7.","journal-title":"Cell metabolism."},{"issue":"29","key":"3055_CR105","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.3748\/wjg.v11.i29.4530","volume":"11","author":"LG Liu","year":"2005","unstructured":"Liu LG, Yan H, Yao P, Zhang W, Zou LJ, Song FF, et al. CYP2E1-dependent hepatotoxicity and oxidative damage after ethanol administration in human primary hepatocytes. World J Gastroenterol. 2005;11(29):4530\u20135.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3055_CR106","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1038\/s41467-023-39028-w","volume":"14","author":"L Gan","year":"2023","unstructured":"Gan L, Feng Y, Du B, Fu H, Tian Z, Xue G, et al. Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae. Nat Commun. 2023;14(1):3215.","journal-title":"Nat Commun"},{"issue":"4","key":"3055_CR107","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00535-025-02332-x","volume":"61","author":"X Ren","year":"2026","unstructured":"Ren X, Yan C, Liu X, Jia X, Chen Y, Zhao H, et al. Bifidobacterium bifidum CIP-01 attenuates metabolic dysfunction-associated steatotic liver disease induced by high-alcohol-producing Klebsiella pneumoniae. J Gastroenterol. 2026;61(4):462\u201376.","journal-title":"J Gastroenterol"},{"issue":"1","key":"3055_CR108","doi-asserted-by":"publisher","first-page":"2304159","DOI":"10.1080\/19490976.2024.2304159","volume":"16","author":"H Li","year":"2024","unstructured":"Li H, Wang X-K, Tang M, Lei L, Li J-R, Sun H, et al. Bacteroides thetaiotaomicron ameliorates mouse hepatic steatosis through regulating gut microbial composition, gut-liver folate and unsaturated fatty acids metabolism. Gut Microbes. 2024;16(1):2304159.","journal-title":"Gut Microbes"},{"key":"3055_CR109","doi-asserted-by":"publisher","first-page":"117156","DOI":"10.1016\/j.biopha.2024.117156","volume":"178","author":"C Sun","year":"2024","unstructured":"Sun C, Xiong X, Liu M, Liang Q, Zhao Q, Wei G, et al. Bacteroides ovatus alleviates high-fat and high-cholesterol-induced nonalcoholic fatty liver disease via gut-liver axis. Biomed Pharmacother. 2024;178:117156.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3055_CR110","doi-asserted-by":"publisher","first-page":"2541035","DOI":"10.1080\/19490976.2025.2541035","volume":"17","author":"B Groenewegen","year":"2025","unstructured":"Groenewegen B, Ruissen MM, Crossette E, Menon R, Prince AL, Norman JM, et al. Consecutive fecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial. Gut Microbes. 2025;17(1):2541035.","journal-title":"Gut Microbes"},{"key":"3055_CR111","doi-asserted-by":"publisher","first-page":"1723128","DOI":"10.3389\/fcell.2026.1723128","volume":"14","author":"F Mi","year":"2026","unstructured":"Mi F, Guo J, Zheng W, Shen J, Ye H. Fecal microbiota transplantation alleviates steatosis and inflammation in high-fat and high-sugar diet-induced fatty liver in mice. Front Cell Dev Biol. 2026;14:1723128.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"3055_CR112","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","volume":"71","author":"J Mouries","year":"2019","unstructured":"Mouries J, Brescia P, Silvestri A, Spadoni I, Sorribas M, Wiest R, et al. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. J Hepatol. 2019;71(6):1216\u201328.","journal-title":"J Hepatol"},{"issue":"2","key":"3055_CR113","first-page":"452","volume":"11","author":"L Liu","year":"2022","unstructured":"Liu L, Yin M, Gao J, Yu C, Lin J, Wu A, et al. Intestinal barrier function in the pathogenesis of nonalcoholic fatty liver disease. J Clin Transl Hepatol. 2022;11(2):452.","journal-title":"J Clin Transl Hepatol"},{"issue":"6262","key":"3055_CR114","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1126\/science.aad0135","volume":"350","author":"I Spadoni","year":"2015","unstructured":"Spadoni I, Zagato E, Bertocchi A, Paolinelli R, Hot E, Di Sabatino A, et al. A gut-vascular barrier controls the systemic dissemination of bacteria. Science. 2015;350(6262):830\u20134.","journal-title":"Science"},{"issue":"6","key":"3055_CR115","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/hep.22848","volume":"49","author":"L Miele","year":"2009","unstructured":"Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49(6):1877\u201387.","journal-title":"Hepatology"},{"issue":"12","key":"3055_CR116","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1111\/liv.14696","volume":"40","author":"TJ De Munck","year":"2020","unstructured":"De Munck TJ, Xu P, Verwijs HJ, Masclee AA, Jonkers D, Verbeek J, et al. Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta-analysis. Liver Int. 2020;40(12):2906\u201316.","journal-title":"Liver Int"},{"issue":"3","key":"3055_CR117","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/liv.15823","volume":"44","author":"Z Ke","year":"2024","unstructured":"Ke Z, Huang Y, Xu J, Liu Y, Zhang Y, Wang Y, et al. Escherichia coli NF73-1 disrupts the gut\u2013vascular barrier and aggravates high-fat diet-induced fatty liver disease via inhibiting Wnt\/\u03b2-catenin signalling pathway. Liver Int. 2024;44(3):776\u201390.","journal-title":"Liver Int"},{"issue":"1","key":"3055_CR118","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s42255-024-01177-7","volume":"7","author":"X Zhang","year":"2025","unstructured":"Zhang X, Lau HC-H, Ha S, Liu C, Liang C, Lee HW, et al. Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut\u2013liver axis. Nat Metab. 2025;7(1):102\u201319.","journal-title":"Nat Metab"},{"key":"3055_CR119","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41467-025-67034-7","volume":"17","author":"Z Li","year":"2025","unstructured":"Li Z, Gu R, Liu D, Zhang Y, Qin Y, Li X, et al. Lack of intestinal Mucin-1 impairs intestinal epithelial barrier and promotes metabolic dysfunction-associated steatotic liver disease in male mice. Nat Commun. 2025;17:321.","journal-title":"Nat Commun."},{"issue":"12","key":"3055_CR120","doi-asserted-by":"publisher","first-page":"e0572","DOI":"10.1097\/HC9.0000000000000572","volume":"8","author":"M Xu","year":"2024","unstructured":"Xu M, Taylor MS, Hill BG, Li X, Rouchka EC, McClain CJ, et al. Intestine epithelial\u2013specific hypoxia-inducible factor-1\u03b1 overexpression ameliorates western diet\u2013induced MASLD. Hepatol Commun. 2024;8(12):e0572.","journal-title":"Hepatol Commun"},{"issue":"1","key":"3055_CR121","doi-asserted-by":"publisher","first-page":"2608437","DOI":"10.1080\/19490976.2025.2608437","volume":"18","author":"EV Jones","year":"2026","unstructured":"Jones EV, Wang Y, Wei W, Reed JC, Chaudhari SN, Li DK, et al. Bile salt hydrolase activity as a rational target for MASLD therapy. Gut Microbes. 2026;18(1):2608437.","journal-title":"Gut Microbes"},{"issue":"7456","key":"3055_CR122","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499(7456):97\u2013101.","journal-title":"Nature"},{"issue":"1","key":"3055_CR123","doi-asserted-by":"publisher","first-page":"2200597","DOI":"10.1002\/mnfr.202200597","volume":"67","author":"M Zheng","year":"2023","unstructured":"Zheng M, Yang X, Wu Q, Gong Y, Pang N, Ge X, et al. Butyrate attenuates hepatic steatosis induced by a high-fat and fiber-deficient diet via the hepatic GPR41\/43-CaMKII\/HDAC1-CREB pathway. Mol Nutr Food Res. 2023;67(1):2200597.","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"3055_CR124","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/ijms27010468","volume":"27","author":"M Liu","year":"2026","unstructured":"Liu M, Wang Y, Huang H. Gut microbiota-derived propionic acid mediates ApoA-I-induced amelioration of MASLD via activation of GPR43-Ca(2+)-CAMKII-ATGL hepatic lipolysis. Int J Mol Sci. 2026;27(1):468.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3055_CR125","doi-asserted-by":"publisher","first-page":"2274124","DOI":"10.1080\/19490976.2023.2274124","volume":"15","author":"Q Wang","year":"2023","unstructured":"Wang Q, Lin H, Shen C, Zhang M, Wang X, Yuan M, et al. Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling. Gut Microbes. 2023;15(2):2274124.","journal-title":"Gut Microbes"},{"issue":"1","key":"3055_CR126","doi-asserted-by":"publisher","first-page":"2424907","DOI":"10.1080\/19490976.2024.2424907","volume":"16","author":"G Musso","year":"2024","unstructured":"Musso G, Alberto M, Mariano F, Cassader M, De Michieli F, Riva A, et al. Impaired postprandial GLP-2 response enhances endotoxemia, systemic inflammation, and kidney injury in metabolic dysfunction-associated steatohepatitis (MASH): effect of phospholipid curcumin meriva. Gut Microbes. 2024;16(1):2424907.","journal-title":"Gut Microbes"},{"key":"3055_CR127","doi-asserted-by":"publisher","first-page":"106037","DOI":"10.1016\/j.ebiom.2025.106037","volume":"122","author":"R Chen","year":"2025","unstructured":"Chen R, Qian J, Wang Q, Li Y, Xu Z, Zhang M, et al. Periodontitis exacerbates metabolic dysfunction-associated steatotic liver disease via the gut microbiota-derived tryptophan metabolism-AHR axis in obesity. EBioMedicine. 2025;122:106037.","journal-title":"EBioMedicine"},{"key":"3055_CR128","doi-asserted-by":"publisher","first-page":"e14830","DOI":"10.1002\/advs.202514830","volume":"13","author":"S Qiao","year":"2026","unstructured":"Qiao S, Fan S, Xu J, Xu Z, Peng C, Qu J, et al. Gut mycobiota\u2010associated tryptophan catabolites protect against metabolic dysfunction\u2010associated steatotic liver disease. Adv Sci (Weinh). 2026;13:e14830.","journal-title":"Adv Sci (Weinh)"},{"issue":"7341","key":"3055_CR129","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, DuGar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57\u201363.","journal-title":"Nature"},{"key":"3055_CR130","doi-asserted-by":"publisher","first-page":"113173","DOI":"10.1016\/j.intimp.2024.113173","volume":"142","author":"F Nian","year":"2024","unstructured":"Nian F, Chen Y, Xia Q, Zhu C, Wu L, Lu X. Gut microbiota metabolite trimethylamine N-oxide promoted NAFLD progression by exacerbating intestinal barrier disruption and intrahepatic cellular imbalance. Int Immunopharmacol. 2024;142:113173.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3055_CR131","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/HEP.0000000000000985","volume":"82","author":"S Hai","year":"2025","unstructured":"Hai S, Li X, Xie E, Wu W, Gao Q, Yu B, et al. Intestinal IL-33 promotes microbiota-derived trimethylamine N-oxide synthesis and drives metabolic dysfunction\u2013associated steatotic liver disease progression by exerting dual regulation on HIF-1\u03b1. Hepatology. 2025;82(1):184\u201398.","journal-title":"Hepatology"},{"issue":"1","key":"3055_CR132","doi-asserted-by":"publisher","first-page":"2500099","DOI":"10.1080\/19490976.2025.2500099","volume":"17","author":"H Wu","year":"2025","unstructured":"Wu H, Chen J, Guo S, Deng J, Zhou Z, Zhang X, et al. Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease. Gut Microbes. 2025;17(1):2500099.","journal-title":"Gut Microbes"},{"issue":"4","key":"3055_CR133","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/gutjnl-2015-310904","volume":"66","author":"T Duparc","year":"2017","unstructured":"Duparc T, Plovier H, Marrachelli VG, Van Hul M, Essaghir A, St\u00e5hlman M, et al. Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism. Gut. 2017;66(4):620\u201332.","journal-title":"Gut"},{"key":"3055_CR134","doi-asserted-by":"crossref","unstructured":"Jyotsna, Sarkar B, Yadav M, Deka A, Markandey M, Sanyal P, et al. A hepatocyte-specific transcriptional program driven by Rela and Stat3 exacerbates experimental colitis in mice by modulating bile synthesis. Elife. 2024;12:RP93273.","DOI":"10.7554\/eLife.93273"},{"issue":"11","key":"3055_CR135","doi-asserted-by":"publisher","first-page":"101148","DOI":"10.1016\/j.jhepr.2024.101148","volume":"6","author":"J Gillard","year":"2024","unstructured":"Gillard J, Roumain M, Picalausa C, Thibaut MM, Clerbaux L-A, Tailleux A, et al. A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH. JHEP Reports. 2024;6(11):101148.","journal-title":"JHEP Reports"},{"issue":"1","key":"3055_CR136","doi-asserted-by":"publisher","first-page":"19580","DOI":"10.1038\/s41598-024-70254-4","volume":"14","author":"SJ Kwon","year":"2024","unstructured":"Kwon SJ, Kim YS, Tak J, Lee SG, Lee EB, Kim SG. Hepatic G\u03b113 ablation shifts region-specific colonic inflammatory status by modulating the bile acid synthetic pathway in mice. Sci Rep. 2024;14(1):19580.","journal-title":"Sci Rep"},{"issue":"10","key":"3055_CR137","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.bbalip.2019.05.014","volume":"1864","author":"C Xie","year":"2019","unstructured":"Xie C, Takahashi S, Brocker CN, He S, Chen L, Xie G, et al. Hepatocyte peroxisome proliferator-activated receptor \u03b1 regulates bile acid synthesis and transport. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(10):1396\u2013411.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"5","key":"3055_CR138","doi-asserted-by":"publisher","first-page":"100344","DOI":"10.1016\/j.jhepr.2021.100344","volume":"3","author":"N Ijssennagger","year":"2021","unstructured":"Ijssennagger N, van Rooijen KS, Magn\u00fasd\u00f3ttir S, Pittol JMR, Willemsen EC, de Zoete MR, et al. Ablation of liver Fxr results in an increased colonic mucus barrier in mice. JHEP Reports. 2021;3(5):100344.","journal-title":"JHEP Reports"},{"issue":"5","key":"3055_CR139","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jhep.2023.12.024","volume":"80","author":"C Zheng","year":"2024","unstructured":"Zheng C, Wang L, Zou T, Lian S, Luo J, Lu Y, et al. Ileitis promotes MASLD progression via bile acid modulation and enhanced TGR5 signaling in ileal CD8+ T cells. J Hepatol. 2024;80(5):764\u201377.","journal-title":"J Hepatol"},{"issue":"8","key":"3055_CR140","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1136\/gutjnl-2018-317232","volume":"68","author":"T Hendrikx","year":"2019","unstructured":"Hendrikx T, Duan Y, Wang Y, Oh J-H, Alexander LM, Huang W, et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice. Gut. 2019;68(8):1504\u201315.","journal-title":"Gut"},{"key":"3055_CR141","doi-asserted-by":"publisher","first-page":"112177","DOI":"10.1016\/j.mce.2024.112177","volume":"585","author":"IML Vasques-Monteiro","year":"2024","unstructured":"Vasques-Monteiro IML, Fernandes-da-Silva A, Miranda CS, Silva-Veiga FM, Daleprane JB, Souza-Mello V. Anti-steatotic effects of PPAR-alpha and gamma involve gut-liver axis modulation in high-fat diet-fed mice. Mol Cell Endocrinol. 2024;585:112177.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"3055_CR142","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","volume":"2","author":"T Inagaki","year":"2005","unstructured":"Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2005;2(4):217\u201325.","journal-title":"Cell Metab"},{"issue":"7","key":"3055_CR143","doi-asserted-by":"publisher","first-page":"e174164","DOI":"10.1172\/jci.insight.174164","volume":"9","author":"N Bozadjieva-Kramer","year":"2024","unstructured":"Bozadjieva-Kramer N, Shin JH, Li Z, Rupp AC, Miller N, Kernodle S, et al. Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance. JCI Insight. 2024;9(7):e174164.","journal-title":"JCI Insight"},{"key":"3055_CR144","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.freeradbiomed.2022.12.087","volume":"195","author":"D Lin","year":"2023","unstructured":"Lin D, Sun Q, Liu Z, Pan J, Zhu J, Wang S, et al. Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice. Free Radic Biol Med. 2023;195:199\u2013218.","journal-title":"Free Radic Biol Med"},{"key":"3055_CR145","doi-asserted-by":"publisher","first-page":"122231","DOI":"10.1016\/j.lfs.2023.122231","volume":"334","author":"X Ye","year":"2023","unstructured":"Ye X, Sun P, Lao S, Wen M, Zheng R, Lin Y, et al. Fgf21-Dubosiella axis mediates the protective effects of exercise against NAFLD development. Life Sci. 2023;334:122231.","journal-title":"Life Sci"},{"issue":"7800","key":"3055_CR146","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-020-2101-7","volume":"579","author":"S Zhao","year":"2020","unstructured":"Zhao S, Jang C, Liu J, Uehara K, Gilbert M, Izzo L, et al. Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. Nature. 2020;579(7800):586\u201391.","journal-title":"Nature"},{"key":"3055_CR147","doi-asserted-by":"publisher","first-page":"123164","DOI":"10.1016\/j.lfs.2024.123164","volume":"358","author":"YD Pinanga","year":"2024","unstructured":"Pinanga YD, Pyo KH, Shin EA, Lee H, Lee EH, Kim W, et al. Association between hepatocyte TM4SF5 expression and gut microbiome dysbiosis during non-alcoholic fatty liver disease development. Life Sci. 2024;358:123164.","journal-title":"Life Sci"},{"key":"3055_CR148","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12866-026-04711-7","volume":"26","author":"CR Hu","year":"2026","unstructured":"Hu CR, Zeng CF, Li H, Wei M, Liu SQ, Li LY, et al. Multi-omics analysis of the gut-liver axis revealed the effects of different exercise interventions in NAFLD mice. BMC Microbiol. 2026;26:254.","journal-title":"BMC Microbiol"},{"key":"3055_CR149","first-page":"nuaf145","volume":"84","author":"X Huang","year":"2025","unstructured":"Huang X, Yu R, Guo M, Tan X, Xia Y, Zou H, et al. Exercise-based interventions for metabolic dysfunction\u2013associated fatty liver disease: an umbrella review of systematic reviews and meta-analyses. Nutr Rev. 2025;84:nuaf145.","journal-title":"Nutr Rev"},{"issue":"10","key":"3055_CR150","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/metabo13101074","volume":"13","author":"D Voudouris","year":"2023","unstructured":"Voudouris D, Horianopoulou M, Apostolopoulou Z, Chryssanthopoulos C, Bardopoulou M, Maridaki M, et al. The effects of a short-term combined exercise program on liver steatosis indices and the lipidemic and glycemic profile in NAFLD individuals: A pilot study. Metabolites. 2023;13(10):1074.","journal-title":"Metabolites"},{"key":"3055_CR151","doi-asserted-by":"crossref","unstructured":"Hashida R, Kawaguchi T, Bekki M, Omoto M, Matsuse H, Nago T, et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review. J Hepatol. 2017;66(1):142\u201352.","DOI":"10.1016\/j.jhep.2016.08.023"},{"issue":"9","key":"3055_CR152","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1136\/gut.2011.242073","volume":"60","author":"K Hallsworth","year":"2011","unstructured":"Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut. 2011;60(9):1278\u201383.","journal-title":"Gut"},{"issue":"3","key":"3055_CR153","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1210\/clinem\/dgab795","volume":"107","author":"A Sabag","year":"2022","unstructured":"Sabag A, Barr L, Armour M, Armstrong A, Baker CJ, Twigg SM, et al. The effect of high-intensity interval training vs moderate-intensity continuous training on liver fat: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2022;107(3):862\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3055_CR154","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000539371","volume":"17","author":"EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","year":"2024","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obes Facts. 2024;17(4):374\u2013444.","journal-title":"Obes Facts"},{"key":"3055_CR155","doi-asserted-by":"publisher","first-page":"101125","DOI":"10.1016\/j.jshs.2026.101125","volume":"15","author":"X Tan","year":"2026","unstructured":"Tan X, Zou H, Guo M, Liu J, Huang X, Yu R, et al. Dose\u2012response relationship between exercise and hepatic steatosis: a systematic review with Bayesian network meta-analysis of randomized controlled trials. J Sport Health Sci. 2026;15:101125.","journal-title":"J Sport Health Sci"},{"issue":"1","key":"3055_CR156","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jhep.2015.02.022","volume":"63","author":"SE Keating","year":"2015","unstructured":"Keating SE, Hackett DA, Parker HM, O\u2019Connor HT, Gerofi JA, Sainsbury A, et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. J Hepatol. 2015;63(1):174\u201382.","journal-title":"J Hepatol"},{"issue":"3","key":"3055_CR157","doi-asserted-by":"publisher","first-page":"e70252","DOI":"10.1111\/sms.70252","volume":"36","author":"PL Hsieh","year":"2026","unstructured":"Hsieh PL, Liu CJ, Wu CH, Wu WK, Wang LY. Self-directed high-intensity interval versus moderate continuous training on cardiometabolic health in metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial. Scand J Med Sci Sports. 2026;36(3):e70252.","journal-title":"Scand J Med Sci Sports"},{"key":"3055_CR158","doi-asserted-by":"publisher","first-page":"1609751","DOI":"10.3389\/fmed.2025.1609751","volume":"12","author":"D Dongkun","year":"2025","unstructured":"Dongkun D, Qingfeng J, Chang L, Yunhua L, Jiaming S, Yufei L, et al. Comparative effects of different loads of aerobic exercise on lipid metabolism in MASLD rats: a perspective from the gut-liver axis. Front Med. 2025;12:1609751.","journal-title":"Front Med"},{"issue":"1","key":"3055_CR159","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12944-025-02565-y","volume":"24","author":"D Deng","year":"2025","unstructured":"Deng D, Xu L, Liu Y, Li C, Jiang Q, Shi J, et al. HIIT versus MICT in MASLD: mechanisms mediated by gut-liver axis crosstalk, mitochondrial dynamics remodeling, and adipokine signaling attenuation. Lipids Health Dis. 2025;24(1):144.","journal-title":"Lipids Health Dis"},{"issue":"33","key":"3055_CR160","doi-asserted-by":"publisher","first-page":"13705","DOI":"10.1073\/pnas.1110105108","volume":"108","author":"R Rab\u00f8l","year":"2011","unstructured":"Rab\u00f8l R, Petersen KF, Dufour S, Flannery C, Shulman GI. Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals. Proc Natl Acad Sci U S A. 2011;108(33):13705\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3055_CR161","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1042\/CS20150447","volume":"130","author":"DJ Cuthbertson","year":"2016","unstructured":"Cuthbertson DJ, Shojaee-Moradie F, Sprung VS, Jones H, Pugh CJ, Richardson P, et al. Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease. Clin Sci (Lond). 2016;130(2):93\u2013104.","journal-title":"Clin Sci (Lond)"},{"issue":"8","key":"3055_CR162","doi-asserted-by":"publisher","first-page":"e70003","DOI":"10.1111\/jpi.70003","volume":"76","author":"A Kovynev","year":"2024","unstructured":"Kovynev A, Ying Z, Zhang S, Olgiati E, Lambooij JM, Visentin C, et al. Timing matters: late, but not early, exercise training ameliorates MASLD in part by modulating the Gut-liver axis in mice. J Pineal Res. 2024;76(8):e70003.","journal-title":"J Pineal Res"},{"issue":"1","key":"3055_CR163","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cgh.2016.07.031","volume":"15","author":"D Houghton","year":"2017","unstructured":"Houghton D, Thoma C, Hallsworth K, Cassidy S, Hardy T, Burt AD, et al. Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial. Clin Gastroenterol Hepatol. 2017;15(1):96-102.e3.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"3055_CR164","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1038\/s41598-025-87190-6","volume":"15","author":"X Yuan","year":"2025","unstructured":"Yuan X, Sun W, Xu Y, Xiang M, Gao Y, Feng W, et al. Altered mitochondrial unfolded protein response and FGF21 secretion in MASLD progression and the effect of exercise intervention. Sci Rep. 2025;15(1):3686.","journal-title":"Sci Rep"},{"issue":"2","key":"3055_CR165","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/hep4.1808","volume":"6","author":"O Glass","year":"2022","unstructured":"Glass O, Liu D, Bechard E, Guy CD, Pendergast J, Mae Diehl A, et al. Perceptions of exercise and its challenges in patients with nonalcoholic fatty liver disease: a survey-based study. Hepatol Commun. 2022;6(2):334\u201344.","journal-title":"Hepatol Commun"},{"key":"3055_CR166","doi-asserted-by":"publisher","first-page":"119314","DOI":"10.1016\/j.lfs.2021.119314","volume":"273","author":"H Li","year":"2021","unstructured":"Li H, Dun Y, Zhang W, You B, Liu Y, Fu S, et al. Exercise improves lipid droplet metabolism disorder through activation of AMPK-mediated lipophagy in NAFLD. Life Sci. 2021;273:119314.","journal-title":"Life Sci"},{"issue":"11","key":"3055_CR167","doi-asserted-by":"publisher","first-page":"e0333872","DOI":"10.1371\/journal.pone.0333872","volume":"20","author":"B Wu","year":"2025","unstructured":"Wu B, Zhang Z, Xu C, Zhao J. Aerobic exercise improved liver steatosis by modulating miR-34a-mediated PPAR\u03b1\/SIRT1-AMPK signaling pathway. PLoS ONE. 2025;20(11):e0333872.","journal-title":"PLoS ONE"},{"key":"3055_CR168","doi-asserted-by":"publisher","first-page":"118868","DOI":"10.1016\/j.lfs.2020.118868","volume":"266","author":"TA Diniz","year":"2021","unstructured":"Diniz TA, de Lima Junior EA, Teixeira AA, Biondo LA, da Rocha LAF, Valad\u00e3o IC, et al. Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-\u03b1 signaling in obese mice. Life Sci. 2021;266:118868.","journal-title":"Life Sci"},{"issue":"6","key":"3055_CR169","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/hep.25548","volume":"55","author":"S Sullivan","year":"2012","unstructured":"Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology. 2012;55(6):1738\u201345.","journal-title":"Hepatology"},{"issue":"11","key":"3055_CR170","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1210\/jc.2016-2353","volume":"101","author":"F Shojaee-Moradie","year":"2016","unstructured":"Shojaee-Moradie F, Cuthbertson DJ, Barrett M, Jackson NC, Herring R, Thomas EL, et al. Exercise training reduces liver fat and increases rates of VLDL clearance but not VLDL production in NAFLD. J Clin Endocrinol Metab. 2016;101(11):4219\u201328.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3055_CR171","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1055\/s-0028-1102937","volume":"41","author":"NA Chapados","year":"2009","unstructured":"Chapados NA, Seelaender M, Levy E, Lavoie JM. Effects of exercise training on hepatic microsomal triglyceride transfer protein content in rats. Horm Metab Res. 2009;41(4):287\u201393.","journal-title":"Horm Metab Res"},{"issue":"1","key":"3055_CR172","doi-asserted-by":"publisher","first-page":"8391","DOI":"10.1038\/s41467-023-44242-7","volume":"14","author":"M Chen","year":"2023","unstructured":"Chen M, Zhu JY, Mu WJ, Luo HY, Li Y, Li S, et al. Cdo1-Camkk2-AMPK axis confers the protective effects of exercise against NAFLD in mice. Nat Commun. 2023;14(1):8391.","journal-title":"Nat Commun"},{"issue":"18","key":"3055_CR173","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.3390\/nu17182972","volume":"17","author":"JM McCaffrey","year":"2025","unstructured":"McCaffrey JM, Ibdah JA. Effects of diet and exercise on mitochondrial health in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): role of ceramides. Nutrients. 2025;17(18):2972.","journal-title":"Nutrients"},{"key":"3055_CR174","doi-asserted-by":"publisher","first-page":"155241","DOI":"10.1016\/j.metabol.2022.155241","volume":"134","author":"JY Zhu","year":"2022","unstructured":"Zhu JY, Chen M, Mu WJ, Luo HY, Guo L. Higd1a facilitates exercise-mediated alleviation of fatty liver in diet-induced obese mice. Metabolism. 2022;134:155241.","journal-title":"Metabolism"},{"issue":"1","key":"3055_CR175","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s13105-026-01167-1","volume":"82","author":"S Yuan","year":"2026","unstructured":"Yuan S, Liu J, Wu J, He J, Qiu L. Exercise attenuates high-fat diet-induced liver injury in mice via PPAR\u03b1 pathway and reduction of oxidative stress and inflammation. J Physiol Biochem. 2026;82(1):22.","journal-title":"J Physiol Biochem."},{"issue":"1","key":"3055_CR176","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s10020-023-00740-4","volume":"29","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Xu J, Zhou D, Ye T, Zhou P, Liu Z, et al. Swimming exercise ameliorates insulin resistance and nonalcoholic fatty liver by negatively regulating PPAR\u03b3 transcriptional network in mice fed high fat diet. Mol Med. 2023;29(1):150.","journal-title":"Mol Med"},{"key":"3055_CR177","doi-asserted-by":"publisher","first-page":"155916","DOI":"10.1016\/j.metabol.2024.155916","volume":"155","author":"HY Luo","year":"2024","unstructured":"Luo HY, Mu WJ, Chen M, Zhu JY, Li Y, Li S, et al. Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice. Metabolism. 2024;155:155916.","journal-title":"Metabolism"},{"key":"3055_CR178","doi-asserted-by":"publisher","first-page":"fuaf037","DOI":"10.1093\/femsre\/fuaf037","volume":"49","author":"AE Mohr","year":"2025","unstructured":"Mohr AE, Mach N, Pugh J, Grosicki GJ, Allen JM, Karl JP, et al. Mechanisms underlying alterations of the gut microbiota by exercise and their role in shaping ecological resilience. FEMS Microbiol Rev. 2025;49:fuaf037.","journal-title":"FEMS Microbiol Rev"},{"issue":"5","key":"3055_CR179","doi-asserted-by":"publisher","first-page":"E864","DOI":"10.1152\/ajpendo.00644.2020","volume":"320","author":"KE Mercer","year":"2021","unstructured":"Mercer KE, Maurer A, Pack LM, Ono-Moore K, Spray BJ, Campbell C, et al. Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women. Am J Physiol Endocrinol Metabol. 2021;320(5):E864\u201373.","journal-title":"Am J Physiol Endocrinol Metabol"},{"issue":"1","key":"3055_CR180","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12876-025-03826-x","volume":"25","author":"J Shi","year":"2025","unstructured":"Shi J, Cui J, Zheng T, Han X, Wang B, Wang W, et al. Comparative effects of aerobic and resistance exercise on bile acid profiles and liver function in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2025;25(1):239.","journal-title":"BMC Gastroenterol"},{"key":"3055_CR181","doi-asserted-by":"publisher","first-page":"110447","DOI":"10.1016\/j.jnutbio.2026.110447","volume":"157","author":"X Zhang","year":"2026","unstructured":"Zhang X, Wang XR, Gai SL, Han YQ, Quan XY, Yin S, et al. Gut microbiota reshaped by exercise improved glycolipid metabolism in obese mice via increasing the production of medium and long chain fatty acids: a multi-omics study. J Nutr Biochem. 2026;157:110447.","journal-title":"J Nutr Biochem"},{"issue":"10","key":"3055_CR182","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1152\/japplphysiol.00693.2015","volume":"120","author":"EL Kullman","year":"2016","unstructured":"Kullman EL, Kelly KR, Haus JM, Fealy CE, Scelsi AR, Pagadala MR, et al. Short-term aerobic exercise training improves gut peptide regulation in nonalcoholic fatty liver disease. J Appl Physiol (1985). 2016;120(10):1159\u201364.","journal-title":"J Appl Physiol (1985)"},{"issue":"18","key":"3055_CR183","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1056\/NEJMoa2028198","volume":"384","author":"JR Lundgren","year":"2021","unstructured":"Lundgren JR, Janus C, Jensen SBK, Juhl CR, Olsen LM, Christensen RM, et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. N Engl J Med. 2021;384(18):1719\u201330.","journal-title":"N Engl J Med"},{"key":"3055_CR184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnu.2025.02.007","volume":"47","author":"Y Yao","year":"2025","unstructured":"Yao Y, Hong Q, Ding S, Cui J, Li W, Zhang J, et al. An umbrella review of meta-analyses on the effects of microbial therapy in metabolic dysfunction-associated steatotic liver disease. Clin Nutr. 2025;47:1\u201313.","journal-title":"Clin Nutr"},{"key":"3055_CR185","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3350\/cmh.2025.1099","volume":"32","author":"HA Sohn","year":"2026","unstructured":"Sohn HA, Go H, An TH, Lee JM, Kim HJ, Haam K, et al. DNMT1 facilitates the progression of MASLD by impeding transcription mediated by HNF4\u03b1 and PPAR\u03b1. Clin Mol Hepatol. 2026;32:1201.","journal-title":"Clin Mol Hepatol."},{"issue":"5","key":"3055_CR186","doi-asserted-by":"publisher","first-page":"e70541","DOI":"10.1111\/acel.70541","volume":"25","author":"W Song","year":"2026","unstructured":"Song W, Wu N, Li X, Li D, Li J, Liu S, et al. Exosome-delivered eNAMPT from exercise activates SIRT1 to counteract age-related hepatic steatosis and fibrosis. Aging Cell. 2026;25(5):e70541.","journal-title":"Aging Cell"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-03055-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-03055-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-03055-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:02:33Z","timestamp":1790240553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-03055-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":186,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3055"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-03055-5","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"201"}}